Delivery Order SPE2DB22D3004-SPE2DB24FPH11
Award Date 2/12/24
Potential Completion Date 2/13/24
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,288.04 firm fixed-price delivery order covers the supply of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product, with a performance period through November 2024. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,051.68 and a completion date of June 13, 2025. The award is for the supply of the drug NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product, and has a ceiling value of $1,352.72. The contract is a firm fixed price delivery order with an ultimate completion date of April 2, 2024. This award is associated...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,361.71 firm fixed-price delivery order covers the supply of NAROPIN 0.2% 400 MG/200 ML BTL 200ML, a specialty pharmaceutical product, with a performance period ending on August 30, 2022. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price, valued at $2,665.86, for the supply of a pharmaceutical product, NAROPIN 0.5% 150 MG/30 ML VIAL 30ML. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,801.63 firm fixed-price delivery order is for the supply of NAROPIN 0.5% 100 MG/20 ML VIAL 20ML, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRBJ7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,523.20 delivery order is for the supply of the pharmaceutical product NAROPIN 0.5% 150 MG/30 ML VIAL 30ML. The contract has a firm fixed price and an ultimate completion date of February 13, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564184299 - NAROPIN 0.5% 150 MG/30 ML VIAL 30ML. The $5,266.26 contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- This federal contract award is a delivery order (SPE2DX15D6028|SPE2DX24FWTNT) issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The award, which is not set aside, is for the supply of the pharmaceutical product NAROPIN 0.5% 100MG 1S. The contract has a firm fixed price of $1,875.60 and a completion date of September 25, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,668.07 and is a Firm Fixed Price Delivery Order with a completion date of May 16, 2024. It is not designated as a set-aside contract. The contract covers the procurement of 4564614741 ! NAROPIN 1% 200 MG/20 ML VIAL 20ML, a pharmaceutical product. AmerisourceBergen holds a significant...